Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP260770.RAmf_Mx69nksRReIxuu3IHKz1GOl-YnZh4RQP3EgqjsA8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP260770.RAmf_Mx69nksRReIxuu3IHKz1GOl-YnZh4RQP3EgqjsA8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP260770.RAmf_Mx69nksRReIxuu3IHKz1GOl-YnZh4RQP3EgqjsA8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP260770.RAmf_Mx69nksRReIxuu3IHKz1GOl-YnZh4RQP3EgqjsA8130_provenance.
- NP260770.RAmf_Mx69nksRReIxuu3IHKz1GOl-YnZh4RQP3EgqjsA8130_assertion description "[CCK/gastrin analogs may be a useful new class of receptor-binding peptides for diagnosis and therapy of CCK-B receptor-expressing tumors, such as MTC or small cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP260770.RAmf_Mx69nksRReIxuu3IHKz1GOl-YnZh4RQP3EgqjsA8130_provenance.
- NP260770.RAmf_Mx69nksRReIxuu3IHKz1GOl-YnZh4RQP3EgqjsA8130_assertion evidence source_evidence_literature NP260770.RAmf_Mx69nksRReIxuu3IHKz1GOl-YnZh4RQP3EgqjsA8130_provenance.
- NP260770.RAmf_Mx69nksRReIxuu3IHKz1GOl-YnZh4RQP3EgqjsA8130_assertion SIO_000772 10452322 NP260770.RAmf_Mx69nksRReIxuu3IHKz1GOl-YnZh4RQP3EgqjsA8130_provenance.
- NP260770.RAmf_Mx69nksRReIxuu3IHKz1GOl-YnZh4RQP3EgqjsA8130_assertion wasDerivedFrom befree-2016 NP260770.RAmf_Mx69nksRReIxuu3IHKz1GOl-YnZh4RQP3EgqjsA8130_provenance.
- NP260770.RAmf_Mx69nksRReIxuu3IHKz1GOl-YnZh4RQP3EgqjsA8130_assertion wasGeneratedBy ECO_0000203 NP260770.RAmf_Mx69nksRReIxuu3IHKz1GOl-YnZh4RQP3EgqjsA8130_provenance.
- befree-2016 importedOn "2016-02-19" NP260770.RAmf_Mx69nksRReIxuu3IHKz1GOl-YnZh4RQP3EgqjsA8130_provenance.